TWC
ABBV icon

TD Waterhouse Canada’s AbbVie ABBV Stock Holding History

TD Waterhouse Canada’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92M Sell
366,299
-136,672
-27% -$29.4M 0.24% 75
2026
Q1 		$108M Buy
502,971
+447,935
+814% +$99.4M 0.32% 61
2025
Q4 		$12.6M Sell
55,036
-53,689
-49% -$12.2M 0.08% 177
2025
Q3 		$26.6M Buy
108,725
+53,885
+98% +$11M 0.17% 110
2025
Q2 		$10.4M Sell
54,840
-15,871
-22% -$2.95M 0.07% 185
2025
Q1 		$14.6M Buy
70,711
+15,113
+27% +$2.94M 0.12% 150
2024
Q4 		$9.88M Buy
55,598
+4,133
+8% +$760K 0.08% 188
2024
Q3 		$10.1M Sell
51,465
-20,437
-28% -$3.81M 0.08% 181
2024
Q2 		$12.3M Buy
71,902
+1,223
+2% +$203K 0.11% 159
2024
Q1 		$13.3M Sell
70,679
-8,206
-10% -$1.41M 0.1% 163
2023
Q4 		$13.3M Sell
78,885
-15,369
-16% -$2.24M 0.12% 135
2023
Q3 		$14.4M Sell
94,254
-4,733
-5% -$695K 0.15% 113
2023
Q2 		$13.9M Sell
98,987
-94,142
-49% -$13.8M 0.14% 116
2023
Q1 		$31.8M Buy
193,129
+25,577
+15% +$3.91M 0.33% 59
2022
Q4 		$27.9M Buy
167,552
+597
+0.4% +$91.5K 0.31% 60
2022
Q3 		$23.6M Sell
166,955
-49,940
-23% -$7.17M 0.27% 67
2022
Q2 		$34M Sell
216,895
-31,330
-13% -$4.79M 0.38% 49
2022
Q1 		$39.7M Buy
248,225
+10,873
+5% +$1.58M 0.39% 54
2021
Q4 		$31.7M Buy
+237,352
New +$28M 0.31% 66

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TD Waterhouse Canada's ABBV Position: Q2 2026 in Review

TD Waterhouse Canada reduced its AbbVie (ABBV) stake by 27% in Q2 2026, selling an estimated $29.4M and leaving 366,299 shares worth $92M. The position accounts for 0.24% of the portfolio, ranked #75.

TD Waterhouse Canada first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $108M in Q1 2026. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TD Waterhouse Canada held 366,299 shares of AbbVie worth $92M as of Q2 2026.
  • TD Waterhouse Canada sold 136,672 AbbVie shares in Q2 2026, an estimated $29.4M.
  • AbbVie made up 0.24% of TD Waterhouse Canada's portfolio in Q2 2026, its #75 holding.
  • TD Waterhouse Canada first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's AbbVie position peaked at $108M in Q1 2026.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.